Literature DB >> 12635056

Ventilator-associated pneumonia: Incidence, risk factors, outcome, and microbiology.

Mandakini Pawar1, Yatin Mehta, Poonam Khurana, Anshumali Chaudhary, Vinay Kulkarni, Naresh Trehan.   

Abstract

OBJECTIVE: To determine the incidence, risk factors, outcome, and pathogens of ventilator-associated pneumonia (VAP) in a cardiac surgical intensive care unit (ICU).
DESIGN: Prospective study.
SETTING: Escorts Heart Institute and Research Centre, New Delhi, India. PARTICIPANTS: Nine hundred fifty-two consecutive patients undergoing cardiac operations who received intermittent positive-pressure ventilation (IPPV).
INTERVENTIONS: All patients were assigned into VAP (n = 25) and non-VAP (n = 927) groups.
MEASUREMENTS AND MAIN RESULTS: Risk factors and other variables were analyzed with univariate and multivariate analysis. Of the 952 patients studied, 25 (2.6%) had VAP. On univariate analysis, significant risk factors were emergency surgery, chronic obstructive pulmonary disease (COPD), reintubation, coma, steroid treatment, intra-aortic balloon counterpulsation (IABC), enteral feedings, tracheostomy, acute physiology, age, and chronic health evaluation (APACHE II) score, prior antibiotics, and IPPV hours. On multivariate analysis, IPPV hours (153.75 +/- 114.44 v 19.65 +/- 7.99; p < 0.001) and steroids (20% v 0%; p < 0.001) were independent predictors of VAP. The most common pathogens isolated were Pseudomonas aeruginosa (22), Escherichia coli (10), Klebsiella pneumoniae (4), Staphylococcus species (4), and Acinetobacter species (2). The mortality rate in VAP was 16% as compared with 0.2% in non-VAP cases (p < 0.001).
CONCLUSION: These data suggest that by univariate analysis the risk factors for VAP were emergency surgery, COPD, reintubation, coma, steroid treatment, IABC, enteral feedings, tracheostomy, APACHE II score, prior antibiotics, and IPPV hours. On multivariate analysis, only IPPV hours and steroids were independent predictors of VAP. Pseudomonas aeruginosa is the most common pathogen associated with VAP, and the mortality is increased with VAP. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12635056     DOI: 10.1053/jcan.2003.4

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  25 in total

1.  Risk factors and outcome of Ventilator Associated Tracheitis (VAT) in pediatric trauma patients.

Authors:  Maroun J Mhanna; Ibrahim S Elsheikh; Dennis M Super
Journal:  Pediatr Pulmonol       Date:  2012-04-24

Review 2.  Pseudomonas aeruginosa, Candida albicans, and device-related nosocomial infections: implications, trends, and potential approaches for control.

Authors:  George E Pierce
Journal:  J Ind Microbiol Biotechnol       Date:  2005-05-03       Impact factor: 3.346

3.  Gastrectomy performed with noninvasive positive pressure ventilation for a patient with severe chronic obstructive pulmonary disease: report of a case.

Authors:  Mami Watanabe; Tatsuo Kanda; Satoshi Maruyama; Yoshiyuki Ikeda; Keiichi Endo; Ritsuko Susa; Katsuyoshi Hatakeyama
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 4.  Noninvasive positive-pressure ventilation as a weaning strategy for intubated adults with respiratory failure.

Authors:  Karen E A Burns; Maureen O Meade; Azra Premji; Neill K J Adhikari
Journal:  Cochrane Database Syst Rev       Date:  2013-12-09

Review 5.  Noninvasive ventilation as a weaning strategy for mechanical ventilation in adults with respiratory failure: a Cochrane systematic review.

Authors:  Karen E A Burns; Maureen O Meade; Azra Premji; Neill K J Adhikari
Journal:  CMAJ       Date:  2013-12-09       Impact factor: 8.262

Review 6.  Acinetobacter infections: a growing threat for critically ill patients.

Authors:  M E Falagas; E A Karveli; I I Siempos; K Z Vardakas
Journal:  Epidemiol Infect       Date:  2007-09-25       Impact factor: 2.451

7.  A comparison of diagnostic algorithms and clinical parameters to diagnose ventilator-associated pneumonia: a prospective observational study.

Authors:  Farshid Rahimibashar; Andrew C Miller; Mojtaba H Yaghoobi; Amir Vahedian-Azimi
Journal:  BMC Pulm Med       Date:  2021-05-13       Impact factor: 3.317

8.  More about chest physiotherapy and ventilator-associated pneumonia prevention.

Authors:  George Ntoumenopoulos
Journal:  Indian J Crit Care Med       Date:  2010-10

9.  Ventilator-associated pneumonia in children after cardiac surgery in The Netherlands.

Authors:  P P Roeleveld; D Guijt; E J Kuijper; M G Hazekamp; R B P de Wilde; E de Jonge
Journal:  Intensive Care Med       Date:  2011-08-30       Impact factor: 17.440

10.  Alcohol-based hand rub and ventilator-associated pneumonia after elective neurosurgery: An interventional study.

Authors:  P P Saramma; K Krishnakumar; P K Dash; P S Sarma
Journal:  Indian J Crit Care Med       Date:  2011-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.